Monk fruit (mogroside V)
Metabolic Health · Non-nutritive sweetener
Tier B
Bottom line
Read Off Label grades Monk fruit (mogroside V) as B (6.8/10) based on moderate evidence, low-moderate benefit magnitude, and a low-risk safety profile.
Human outcome data for monk-fruit sweeteners are limited, and direct comparative trials against aspartame, sucralose, or stevia are sparse.
Studied, labeled, or reported-use context: Sweetness-equivalent substitution is approximately 1:1 for formulated products; commonly blended with… — OTC; not individualized guidance.
What the evidence says
Human outcome data for monk-fruit sweeteners are limited, and direct comparative trials against aspartame, sucralose, or stevia are sparse. Cost, taste, and blended formulations vary; pure mogroside extracts are often blended because of their high sweetness intensity.
Mechanism
Mogroside V and related cucurbitane triterpene glycosides; ~150-250x sweetness of sucrose; not absorbed in small intestine, hydrolyzed by colonic microbiota to mogrol; no glycemic or insulin response in healthy or T2DM
Studied, labeled, or reported dose & route
Sweetness-equivalent substitution is approximately 1:1 for formulated products; commonly blended with allulose or erythritol
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Monk fruit (mogroside V)'s effects?
- Read Off Label rates the evidence for Monk fruit (mogroside V) as Moderate and the benefit magnitude as low-moderate, producing an overall grade of B (6.8/10). Human outcome data for monk-fruit sweeteners are limited, and direct comparative trials against aspartame, sucralose, or stevia are sparse.
- What safety findings are reported for Monk fruit (mogroside V)?
- Monk fruit (mogroside V) has a low risk profile in the database. Low (GRAS 2010; no toxicology signals; rare hypersensitivity) Legal status: OTC.
- What doses or routes are reported for Monk fruit (mogroside V)?
- Sweetness-equivalent substitution is approximately 1:1 for formulated products; commonly blended with allulose or erythritol This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Monk fruit (mogroside V) work?
- Mogroside V and related cucurbitane triterpene glycosides; ~150-250x sweetness of sucrose; not absorbed in small intestine, hydrolyzed by colonic microbiota to mogrol; no glycemic or insulin response in healthy or T2DM
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.